U.S. License Holder:
Accord BioPharma
Date of License:
aBLA submitted to FDA on undisclosed date
Last Update:
Sep-30-2024
FDA-Approved Indications
Pelgraz (pegfilgrastim) is not FDA-approved. A BLA has been submitted to the FDA.
Approved Foreign Follow-On Biologics / Biosimilars
Biosimilars Approved In The E.U.
Pelgraz (Accord Healthcare) (September-2018)